Medical Developments International Limited announced the appointment of Gordon Naylor as a Non-Executive Director of the Company with immediate effect. For over 30 years he was a key part of the internationalization of the CSL Group, a global specialty biotechnology company that was established in Australia. Gordon held a range of business and functional leadership roles within CSL including Chief Financial Officer. At the time of his retirement from CSL, he was the President of Seqirus where he led the 3-year turnaround of that business into one of the most successful vaccine companies in the world.